Raymond James & Associates’s Columbia Seligman Premium Technology Growth Fund STK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$942K Sell
28,122
-32,772
-54% -$1.07M ﹤0.01% 2725
2024
Q2
$2.03M Sell
60,894
-10,510
-15% -$335K ﹤0.01% 2166
2024
Q1
$2.28M Sell
71,404
-3,007
-4% -$96.7K ﹤0.01% 2080
2023
Q4
$2.35M Sell
74,411
-9,354
-11% -$270K ﹤0.01% 2013
2023
Q3
$2.28M Buy
83,765
+10,835
+15% +$320K ﹤0.01% 1946
2023
Q2
$2.24M Buy
72,930
+12,470
+21% +$351K ﹤0.01% 1987
2023
Q1
$1.68M Buy
60,460
+6,049
+11% +$159K ﹤0.01% 2140
2022
Q4
$1.26M Buy
54,411
+1,615
+3% +$40.4K ﹤0.01% 2297
2022
Q3
$1.22M Buy
52,796
+9,786
+23% +$276K ﹤0.01% 2269
2022
Q2
$1.08M Buy
43,010
+245
+0.6% +$6.91K ﹤0.01% 2383
2022
Q1
$1.37M Sell
42,765
-1,377
-3% -$44.9K ﹤0.01% 2395
2021
Q4
$1.63M Buy
44,142
+14,890
+51% +$538K ﹤0.01% 2311
2021
Q3
$964K Buy
29,252
+394
+1% +$13.3K ﹤0.01% 2606
2021
Q2
$1.02M Buy
28,858
+1,027
+4% +$34.7K ﹤0.01% 2576
2021
Q1
$869K Buy
27,831
+25
+0.1% +$740 ﹤0.01% 2601
2020
Q4
$757K Sell
27,806
-724
-3% -$17.7K ﹤0.01% 2526
2020
Q3
$625K Sell
28,530
-5,457
-16% -$122K ﹤0.01% 2474
2020
Q2
$747K Buy
33,987
+20,985
+161% +$433K ﹤0.01% 2337
2020
Q1
$230K Sell
13,002
-35
-0.3% -$775 ﹤0.01% 2940
2019
Q4
$307K Sell
13,037
-805
-6% -$18.2K ﹤0.01% 3070
2019
Q3
$292K Sell
13,842
-1,058
-7% -$22.2K ﹤0.01% 3025
2019
Q2
$305K Sell
14,900
-7,417
-33% -$154K ﹤0.01% 3006
2019
Q1
$448K Sell
22,317
-3,186
-12% -$61.6K ﹤0.01% 2737
2018
Q4
$429K Buy
25,503
+5,695
+29% +$108K ﹤0.01% 2637
2018
Q3
$423K Sell
19,808
-3,450
-15% -$74.8K ﹤0.01% 2823
2018
Q2
$501K Sell
23,258
-19,398
-45% -$430K ﹤0.01% 2688
2018
Q1
$936K Buy
42,656
+8,028
+23% +$181K ﹤0.01% 2181
2017
Q4
$770K Sell
34,628
-27,974
-45% -$642K ﹤0.01% 2271
2017
Q3
$1.4M Sell
62,602
-12,776
-17% -$283K ﹤0.01% 1882
2017
Q2
$1.62M Sell
75,378
-21,909
-23% -$482K ﹤0.01% 1725
2017
Q1
$2.01M Sell
97,287
-787
-0.8% -$15.7K ﹤0.01% 1529
2016
Q4
$1.84M Buy
98,074
+63,878
+187% +$1.17M ﹤0.01% 1537
2016
Q3
$636K Buy
34,196
+12,000
+54% +$214K ﹤0.01% 2126
2016
Q2
$368K Buy
22,196
+4,225
+24% +$70.8K ﹤0.01% 2280
2016
Q1
$323K Buy
17,971
+4,600
+34% +$76.1K ﹤0.01% 2285
2015
Q4
$240K Buy
+13,371
New +$242K ﹤0.01% 2277
2015
Q3
Sell
-17,088
Closed -$319K 2375
2015
Q2
$319K Buy
17,088
+2,310
+16% +$44.5K ﹤0.01% 2256
2015
Q1
$281K Buy
14,778
+3,750
+34% +$69.9K ﹤0.01% 2238
2014
Q4
$209K Sell
11,028
-3,031
-22% -$53.3K ﹤0.01% 2213
2014
Q3
$246K Sell
14,059
-7,429
-35% -$129K ﹤0.01% 2108
2014
Q2
$364K Buy
21,488
+2,607
+14% +$42.8K ﹤0.01% 1976
2014
Q1
$298K Buy
18,881
+3,426
+22% +$52.3K ﹤0.01% 1959
2013
Q4
$222K Buy
15,455
+344
+2% +$4.98K ﹤0.01% 1931
2013
Q3
$215K Buy
+15,111
New +$220K ﹤0.01% 1881

Other funds holding STK

Raymond James & Associates's STK Position: Q3 2024 in Review

Raymond James & Associates reduced its Columbia Seligman Premium Technology Growth Fund (STK) stake by 54% in Q3 2024, selling an estimated $1.07M and leaving 28,122 shares worth $942K. The position accounts for ﹤0.01% of the portfolio, ranked #2725.

Raymond James & Associates first reported a position in STK in Q3 2013 and has held it in 44 quarters since. The position peaked at $2.35M in Q4 2023. 60 funds tracked by Wall St. Rank hold STK as of Q3 2024.

  • Raymond James & Associates held 28,122 shares of Columbia Seligman Premium Technology Growth Fund worth $942K as of Q3 2024.
  • Raymond James & Associates sold 32,772 Columbia Seligman Premium Technology Growth Fund shares in Q3 2024, an estimated $1.07M.
  • Columbia Seligman Premium Technology Growth Fund made up ﹤0.01% of Raymond James & Associates's portfolio in Q3 2024, its #2725 holding.
  • Raymond James & Associates first reported a position in Columbia Seligman Premium Technology Growth Fund in Q3 2013 and has held it in 44 quarters since.
  • Raymond James & Associates's Columbia Seligman Premium Technology Growth Fund position peaked at $2.35M in Q4 2023.
  • 60 funds tracked by Wall St. Rank held Columbia Seligman Premium Technology Growth Fund as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.